Global burden of Alzheimer’s disease and other dementias in adults aged 65 years and over, and health inequality related to SDI, 1990–2021: analysis of data from GBD 2021
Top Cited Papers
Open Access
- 3 April 2025
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-10
Abstract
The disease burden of dementia in the elderly is predicted to rise, and dementia among older adults has become a crucial issue for public health. Quantifying the disease burden of dementia in the elderly can provide relevant areas and countries with scientific data to help them adjust their healthcare strategies. We analyzed the disease burden of Alzheimer’s disease and other dementias among individuals aged 65 and older from 1990 to 2021; the relationship between mortality rates and disability-adjusted life years (DALYs) with socio-demographic index (SDI); conducted a frontier analysis of the disease burden across 204 countries; and quantified inequalities in age-standardized DALYs for Alzheimer’s disease and other dementias using the slope inequality index and concentration index. Globally, age-standardized DALYs and mortality rates for individuals aged 65 and older have declined over time. We find that the disease burden of dementia is significantly associated with SDI. High SDI countries have 169% higher baseline levels of dementia burden compared to low SDI countries, as estimated based on their current level of social development. Finally, our health inequality analyses reveal that while the overall trend of DALYs for dementia increases with SDI, the burden is primarily concentrated in populations with lower SDI, as non-developed countries account for the majority of the population. The global population aged 65 and older experiences a significant reduction in healthy life expectancy due to dementia. The burden of disease in most countries is higher than the minimum disease burden associated with SDI in those countries. The burden of disease in low and middle SDI countries has been showing an increasing trend. The gap in disease burden among regions with different SDI levels is also continuously narrowing.Keywords
Funding Information
- Natural Science Foundation of Jiangxi Province (20232ACB206024)
This publication has 38 references indexed in Scilit:
- Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trialsJournal of Neurology, Neurosurgery & Psychiatry, 2020
- Rheumatic heart disease burden, trends, and inequalities in the Americas, 1990–2017: a population-based studyThe Lancet Global Health, 2019
- Incidence of Dementia and Alzheimer Disease Over Time: A Meta‐AnalysisJournal of the American Geriatrics Society, 2019
- The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer preventionJournal of Hepatology, 2019
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet, 2018
- Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016Kidney International, 2018
- Defeating Alzheimer's disease and other dementias: a priority for European science and societyThe Lancet Neurology, 2016
- Lewy body dementiasThe Lancet, 2015
- Sex differences in cognitive impairment and Alzheimer’s diseaseFrontiers in Neuroendocrinology, 2014
- The Clinical Course of Advanced DementiaNew England Journal of Medicine, 2009